Showing 5431-5440 of 7518 results for "".
- CDC Warns Doctors to Lookout for Flesh-eating Bacteria in Woundshttps://practicaldermatology.com/news/cdc-warns-doctors-to-lookout-for-flesh-eating-bacteria-in-wounds/2461981/Healthcare providers, laboratories, and public health departments need to be on the lookout for Vibrio vulnificus (V. vulnificus) infections in wounds that were exposed to coastal waters, particularly near the Gulf of Mexico or East Coast, and during periods with
- Is PIILIF the Precursor to Scarring Alopecias?https://practicaldermatology.com/news/is-piilif-the-precursor-for-scarring-alopecias/2461978/A single root condition called PIILIF (perifollicular infundibulo-isthmic lymphocytic infiltrates and fibrosis) may be a precursor for acne keloidalis nuchae (AKN) and primary cicatricial alopecias, according to a study in
- Dan Walker Named VP of US Commercial Operations at SciBasehttps://practicaldermatology.com/news/dan-walker-named-vp-of-us-commercial-operations-at-scibase/2461977/Dan Walker is SciBase’s new VP of US Commercial Operations. SciBase's products include Nevisense and Nevisense Go which address melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. Mr. Walker was previously Senior Dire
- Kenvue Launches Two New Tylenol Precise Pain-relieving Creamshttps://practicaldermatology.com/news/kenvue-launches-two-new-tylenol-precise-pain-relieving-creams/2461973/Kenvue Inc. is rolling out two new topical pain-relieving creams: Tylenol Precise Pain Relieving Cream and Tylenol Precise Cooling Pain Relieving Cream. These are among the first U.S. product launches from Kenvue since it became a publicly traded
- Are Wealthy People at Higher Risk for Skin Cancer?https://practicaldermatology.com/news/are-wealthy-people-are-more-prone-to-skin-cancer/2461972/Wealthier people are at greater risk for melanoma, according to new research in Cancers. “A higher socio-economic status is known to be associated with more vacations in sunny climates and recreational tanning, which likely ultimately drives melanoma incidence in this pop
- FDA Clears Sofwave’s SUPERB Technology for Treating Acne Scarshttps://practicaldermatology.com/news/fda-clears-sofwaves-superb-technology-for-treating-acne-scars/2461969/The U.S. Food and Drug Administration (FDA) has cleared Sofwave’s SUPERB technology for treating acne scars. “Gaining FDA clearance to market SUPERB for the treatment of acne scarring not only paves the way to positively impact patients seeking improved appearances
- New CEO for SciBasehttps://practicaldermatology.com/news/new-ceo-for-scibase/2461967/Pia Renaudin is SciBase’s new Chief Executive Officer (CEO), effective October 1st, 2023. SciBase's products include Nevisense and Nevisense Go and address melanoma detection, non-melanoma skin cancer detection and skin barrier assessment. Ms.
- Time Matters When Saving Skin During FLASH Radiotherapyhttps://practicaldermatology.com/news/time-matters-when-saving-skin-during-flash-radiotherapy/2461966/Multiple beams and intervals in delivery during FLASH proton therapy treatment may reduce skin-saving effects in preclinical models, according to a study in the International Journal of Radiation
- Nathalie Daste Named LEO Pharma’s New Executive Vice President of Global People and Corporate Affairshttps://practicaldermatology.com/news/nathalie-daste-named-leo-pharmas-new-executive-vice-president-of-global-people-and-corporate-affairs/2461964/Nathalie Daste is LEO Pharma’s new Executive Vice President, Global People and Corporate Affairs, and member of its Global Leadership Team, effective October 1, 2023. In her new role, Ms. Daste will head LEO Pharma’s Global People function as well as Corporate Affa
- New Kerecis Medical-Fish-Skin Product Approved by Medicare Administrative Contractorshttps://practicaldermatology.com/news/new-kerecis-medical-fish-skin-product-approved-by-medicare-administrative-contractors/2461961/Multiple leading Medicare Administrative Contractors have approved Kerecis Shield, the new fish-skin wound-treatment product. This means that physicians in private clinics will not need to submit invoices for reimbursement, improving efficiency by eliminating a step in the reimbursement proc